Recent advancements in positron emission tomography (PET) have led to the development of tau-specific radiotracers, offering new opportunities in the differential diagnosis of atypical Parkinsonisms, particularly in conditions such as PSP and CBD. Here, MAPT is linked to red-green color blindness.